IM Cannabis Corp. (IMCC) vs China SXT Pharmaceuticals, Inc. (SXTC)
- IM Cannabis Corp. IMCC 1.36 +2.26%
- China SXT Pharmaceuticals, Inc. SXTC 0.07 0.00%
IM Cannabis Corp. and China SXT Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. IM Cannabis Corp. is the larger, with a market value of $2.2M against $710.0K — 3.1× the size. IM Cannabis Corp. grew revenue faster over the last twelve months: −12.0% against −54.0%. IM Cannabis Corp. has the higher net margin (−38.9% vs −255.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, China SXT Pharmaceuticals, Inc. leads on 8 and IM Cannabis Corp. on 7.
Valuation
Profitability
| Metric | IMCC | SXTC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 12.62% | 36.69% | 53.94% |
| Operating margin | (32.88%) | 0.00% | 0.00% |
| Net margin | (38.92%) | (255.16%) | 0.00% |
| Free cash flow margin | (1.47%) | 0.00% | 0.00% |
| Return on equity | 2,280.06% | 0.00% | (0.40%) |
| Return on assets | (54.20%) | 0.00% | (3.32%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack